EyePoint Pharmaceuticals
EYPT
EYPT
37 hedge funds and large institutions have $5.27M invested in EyePoint Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
77% less call options, than puts
Call options by funds: $12K | Put options by funds: $52K
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Holders
37
Holding in Top 10
–
Calls
$12K
Puts
$52K
Top Buyers
| 1 | +$165K | |
| 2 | +$115K | |
| 3 | +$28.4K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.8K |
| 5 |
MAA
Matrix Asset Advisors
White Plains,
New York
|
+$13.2K |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$213K | |
| 3 | -$135K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$135K |
| 5 |
Squarepoint
New York
|
-$100K |